Bruderman Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
– Sell
-8,214
Closed -$304K – 113
2019
Q3
$304K Sell
8,214
-329,031
-98% -$12.6M 0.08% 101
2019
Q2
$14.6M Sell
337,245
-6,461
-2% -$270K 3.45% 5
2019
Q1
$14.6M Sell
343,706
-21,079
-6% -$890K 3.2% 5
2018
Q4
$15.9M Sell
364,785
-1,888
-0.5% -$82.6K 4.1% 3
2018
Q3
$16.2M Buy
366,673
+24,493
+7% +$994K 3.71% 3
2018
Q2
$12.4M Sell
342,180
-2,219
-0.6% -$79.9K 3.02% 7
2018
Q1
$12.2M Sell
344,399
-788
-0.2% -$28.6K 2.93% 9
2017
Q4
$12.5M Buy
345,187
+1,033
+0.3% +$37.1K 3.18% 9
2017
Q3
$12.3M Sell
344,154
-742
-0.2% -$25.1K 3.18% 10
2017
Q2
$11.6M Buy
344,896
+33,462
+11% +$1.11M 3.09% 11
2017
Q1
$10.7M Buy
311,434
+19,172
+7% +$637K 3.08% 9
2016
Q4
$9.49M Buy
292,262
+9,638
+3% +$310K 2.86% 9
2016
Q3
$9.6M Buy
282,624
+30,596
+12% +$1.08M 2.86% 9
2016
Q2
$8.87M Sell
252,028
-1,150
-0.5% -$38.7K 2.78% 9
2016
Q1
$7.5M Buy
253,178
+88,443
+54% +$2.66M 2.61% 11
2015
Q4
$5.32M Buy
164,735
+5,478
+3% +$182K 2% 14
2015
Q3
$5M Buy
159,257
+36,232
+29% +$1.22M 1.97% 17
2015
Q2
$4.12M Buy
123,025
+41,594
+51% +$1.43M 1.58% 18
2015
Q1
$2.83M Hold
81,431
– – 1.11% 23

Other funds holding PFE

Bruderman Asset Management's PFE Position: Q4 2019 in Review

Bruderman Asset Management sold out of Pfizer (PFE) in Q4 2019, closing a stake of 8,214 shares — an estimated $304K sold.

Bruderman Asset Management first reported a position in PFE in Q1 2015 and held it in 19 quarters. The position peaked at $16.2M in Q3 2018. 2,521 funds tracked by Wall St. Rank hold PFE as of Q4 2019.

  • Bruderman Asset Management reported no remaining Pfizer position as of Q4 2019 after selling out during the quarter.
  • Bruderman Asset Management sold 8,214 Pfizer shares in Q4 2019, an estimated $304K.
  • Bruderman Asset Management first reported a position in Pfizer in Q1 2015 and held it in 19 quarters.
  • Bruderman Asset Management's Pfizer position peaked at $16.2M in Q3 2018.
  • 2,521 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.

Based on Bruderman Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.